Clinical activity of leukotriene inhibitors

This publication has 43 references indexed in Scilit:

• Section Review: Recent progress in the development of leukotriene B₄antagonists
  Expert Opinion on Investigational Drugs, 1994
• 5‐Lipoxygenase‐activating protein stimulates the utilization of arachidonic acid by 5‐lipoxygenase
  European Journal of Biochemistry, 1993
• The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitor
  International Journal of Immunopharmacology, 1992
• The Potent and Selective Sulfidopeptide Leukotriene Antagonist, SK&F 104353, Inhibits Aspirin-induced Asthma
  American Review of Respiratory Disease, 1991
• Inhibition of Exercise-Induced Bronchoconstriction by MK-571, a Potent Leukotriene D4–Receptor Antagonist
  New England Journal of Medicine, 1991
• Pharmacologic and Clinical Effects of Lonapalene (RS 43179), a 5-Lipoxygenase Inhibitor, in Psoriasis
  Journal of Investigative Dermatology, 1990
• A double-blind vehicle-controlled study of R 68 151 in psoriasis: A topical 5-lipoxygenase inhibitor
  Journal of the American Academy of Dermatology, 1990
• Eicosanoids and rheumatology: Inflammatory and vascular aspects
  Prostaglandins, Leukotrienes & Essential Fatty Acids, 1989
• Leukotriene B₄Production by Peripheral Blood Neutrophils in Rheumatoid Arthritis
  Scandinavian Journal of Rheumatology, 1989
• Bronchial effects of leukotriene D4 inhalation in normal human lung
  Clinical Science, 1987